Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TC Energy
TRP
|
+$1.7B |
| 2 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$505M |
| 3 |
Johnson & Johnson
JNJ
|
+$441M |
| 4 |
Mastercard
MA
|
+$406M |
| 5 |
iShares US Real Estate ETF
IYR
|
+$394M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.61B |
| 2 |
NVIDIA
NVDA
|
+$1.42B |
| 3 |
Visa
V
|
+$1.16B |
| 4 |
Apple
AAPL
|
+$907M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$716M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.3% |
| 2 | Financials | 8.57% |
| 3 | Healthcare | 7.58% |
| 4 | Consumer Discretionary | 7.43% |
| 5 | Industrials | 5.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5576
Cellectar Biosciences
CLRB
$21.3M
| $43.9K | ﹤0.01% |
684
-483
| -41% | -$31.9K |
|
|
ASM
5577
Avino Silver & Gold Mines
ASM
$969M
| $42.9K | ﹤0.01% |
38,960
+11,379
| +41% | +$11.5K |
|
5578
Innoviz Technologies
INVZ
$90.8M
| $42.8K | ﹤0.01% |
51,640
-130,677
| -72% | -$99.3K |
|
5579
Metagenomi Therapeutics
MGX
$45.6M
| $42.6K | ﹤0.01% |
+19,629
| New | +$68.1K |
|
|
BOLD
5580
Boundless Bio
BOLD
$57.8M
| $39.4K | ﹤0.01% |
+11,356
| New | +$41.2K |
|
|
AZUL
5581
DELISTED
Azul
AZUL
| $39.1K | ﹤0.01% |
+11,353
| New | +$42.7K |
|
5582
Unicycive Therapeutics
UNCY
$138M
| $38.1K | ﹤0.01% |
9,342
+7
| +0.1% | +$28 |
|
|
FORA
5583
DELISTED
Forian
FORA
| $37.4K | ﹤0.01% |
17,312
+59
| +0.3% | +$144 |
|
|
KC
5584
Kingsoft Cloud Holdings
KC
$3.56B
| $36.8K | ﹤0.01% |
12,527
-49,665
| -80% | -$123K |
|
|
XFINW
5585
DELISTED
ExcelFin Acquisition Corp Warrant
XFINW
| $32.8K | ﹤0.01% |
220,001
| – | – |
|
|
VOXR
5586
Vox Royalty Corp
VOXR
$307M
| $32.3K | ﹤0.01% |
10,700
| – | – |
|
|
ME
5587
DELISTED
23andMe Holding Co
ME
| $31.9K | ﹤0.01% |
4,588
-89,428
| -95% | -$667K |
|
|
MIN
5588
Aberdeen Intermediate Income Fund
MIN
$274M
| $31K | ﹤0.01% |
+11,400
| New | +$31K |
|
|
TTOO
5589
DELISTED
T2 Biosystems, Inc
TTOO
| $29.1K | ﹤0.01% |
14,750
+45
| +0.3% | +$171 |
|
5590
Solarmax Technology
SMXT
$20.3M
| $28.9K | ﹤0.01% |
45,754
-30,269
| -40% | -$79.7K |
|
|
ABVE
5591
DELISTED
Above Food Ingredients Inc
ABVE
| $28.6K | ﹤0.01% |
+49,378
| New | +$67.2K |
|
5592
SKYX Platforms
SKYX
$149M
| $28.5K | ﹤0.01% |
33,553
-687,987
| -95% | -$646K |
|
5593
IGC Pharma
IGC
$25.6M
| $28K | ﹤0.01% |
65,541
+46
| +0.1% | +$18 |
|
|
ASRT
5594
DELISTED
Assertio
ASRT
| $25.4K | ﹤0.01% |
1,433
-73,255
| -98% | -$1.45M |
|
|
SHMDW
5595
SCHMID Group N.V. Warrants
SHMDW
| $24.1K | ﹤0.01% |
+75,239
| New | +$29.9K |
|
|
OKUR
5596
OnKure Therapeutics
OKUR
$162M
| $24K | ﹤0.01% |
1,414
-13,017
| -90% | -$193K |
|
5597
Enlivex Ltd
ENLV
$36.5M
| $23.4K | ﹤0.01% |
929
+167
| +22% | +$3.4K |
|
|
WW
5598
DELISTED
WW International
WW
| $23.1K | ﹤0.01% |
26,347
-301,263
| -92% | -$292K |
|
|
KRON
5599
DELISTED
Kronos Bio
KRON
| $21.7K | ﹤0.01% |
21,690
+3,905
| +22% | +$4.32K |
|
5600
MediciNova
MNOV
$65.5M
| $21.5K | ﹤0.01% |
+10,246
| New | +$15.2K |
|
Similar funds
Goldman Sachs's Q3 2024 Portfolio in Review
As of Q3 2024, Goldman Sachs held 6,216 positions worth $621B, up 5% from $591B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Goldman Sachs's Q3 2024 filing shows 596 new, 2,752 increased, 1,995 reduced and 427 closed positions. Its largest new stake was Smurfit Westrock: 3,644,566 shares worth $180M. The largest sale was Tesla, an estimated $1.61B.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 21% a quarter earlier, followed by Financials and Healthcare.
- Goldman Sachs's largest Q3 2024 buy was Smurfit Westrock: 3,644,566 shares worth $180M.
- Goldman Sachs added most to TC Energy in Q3 2024, an estimated $1.7B increase.
- Goldman Sachs's biggest Q3 2024 reduction was Tesla, cutting an estimated $1.61B.
- Goldman Sachs fully exited WestRock Company in Q3 2024, selling an estimated $204M.
- Goldman Sachs's ten largest holdings make up 19% of its $621B portfolio in Q3 2024.
- Goldman Sachs opened 596 new positions and closed 427 in Q3 2024.
- Goldman Sachs's portfolio value rose 5% quarter-over-quarter to $621B.
Based on Goldman Sachs's 13F filing for Q3 2024, filed 14 Nov 2024.